Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Re-Discovery of Pyrimidine Salvage as Target in Cancer Therapy
Melanie Walter, Patrick Herr
Cells (2022) Vol. 11, Iss. 4, pp. 739-739
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Metabolic reprogramming in cancer: Mechanisms and therapeutics
Shiqi Nong, Xiaoyue Han, Xiang Yu, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 100
Regulation of nucleotide metabolism in cancers and immune disorders
Eunüs S. Ali, Issam Ben‐Sahra
Trends in Cell Biology (2023) Vol. 33, Iss. 11, pp. 950-966
Open Access | Times Cited: 47
Plant Foods and Their Bioactives as Dietary Enhancers for Colon Cancer Treatment with 5-Fluorouracil
Zhongming Yang, Carlos L. Céspedes, Zhongguo Yang, et al.
Food Reviews International (2025), pp. 1-50
Closed Access | Times Cited: 7
Combating chemoresistance: Current approaches & nanocarrier mediated targeted delivery
Siuli Shaw, Subrata K. Pore, D.-M. Liu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189261-189261
Closed Access | Times Cited: 1
mTORC1 regulates the pyrimidine salvage pathway by controlling UCK2 turnover via the CTLH-WDR26 E3 ligase
Brittany Q Pham, Sang Ah Yi, Alban Ordureau, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115179-115179
Open Access | Times Cited: 1
Six‐Membered Aromatic Nitrogen Heterocyclic Anti‐Tumor Agents: Synthesis and Applications
Jiatong Li, Ao Gu, Xiao‐Mei Nong, et al.
The Chemical Record (2023) Vol. 23, Iss. 12
Closed Access | Times Cited: 17
Targeting the DNA damage response and repair in cancer through nucleotide metabolism
Thomas Helleday, Sean G. Rudd
Molecular Oncology (2022) Vol. 16, Iss. 21, pp. 3792-3810
Open Access | Times Cited: 27
Interplay between mTOR and Purine Metabolism Enzymes and Its Relevant Role in Cancer
S. Allegrini, Marcella Camici, Mercedes Garcia‐Gil, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6735-6735
Open Access | Times Cited: 6
Integrative Analyses of Pyrimidine Salvage Pathway-Related Genes Revealing the Associations Between UPP1 and Tumor Microenvironment
Yin Li, Manling Jiang, Yongqi Wei, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 101-119
Open Access | Times Cited: 5
A Brief Review on the Synthesis of 4H‐Chromene‐Embedded Heterocycles
K. Nissi Sharon, P. Padmaja, Pedavenkatagari Narayana Reddy
ChemistrySelect (2024) Vol. 9, Iss. 27
Closed Access | Times Cited: 5
Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer
Weili Wu, Yingying Zhao, Baifu Qin, et al.
EBioMedicine (2023) Vol. 93, pp. 104650-104650
Open Access | Times Cited: 13
Active biomonitoring of stream ecosystems: untargeted metabolomic and proteomic responses and free radical scavenging activities in mussels
Muhammad Rivaldi, Andri Frediansyah, Solihatun Amidan Amatul Aziz, et al.
Ecotoxicology (2025)
Open Access
Identification of pyrimidine metabolism-based molecular subtypes and prognostic signature to predict immune landscape and guide clinical treatment in prostate cancer
Yu‐Zhong Yu, Xiao Xie, Maoping Cai, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Vaccinia growth factor-dependent modulation of the mTORC1-CAD axis upon nutrient restriction
Lara Dsouza, Anil Pant, Blake Pope, et al.
Journal of Virology (2025)
Open Access
A critical review on purine and pyrimidine heterocyclic derivatives and their designed molecules in Cancer
Gajanana Sanglikar, Anand KumarTengli
Results in Chemistry (2025), pp. 102210-102210
Open Access
Histology-resolved proteomics reveals distinct tumor and stromal profiles in low- and high-grade prostate cancer
Allison L. Hunt, Waleed Barakat, Sasha C. Makohon‐Moore, et al.
Clinical Proteomics (2025) Vol. 22, Iss. 1
Open Access
Metabolic Pathway Analysis of Tumors Using Stable Isotopes
Qiufen Bi, Junzhang Zhao, Jun Nie, et al.
Seminars in Cancer Biology (2025) Vol. 113, pp. 9-24
Closed Access
Reprogramming of pyrimidine nucleotide metabolism supports vigorous cell proliferation of normal and malignant T cells
Tatsuro Watanabe, Yuta Yamamoto, Yuki Kurahashi, et al.
Blood Advances (2024) Vol. 8, Iss. 6, pp. 1345-1358
Open Access | Times Cited: 3
Effects of metabolic cancer therapy on tumor microenvironment
Petra Hyroššová, Mirko Milošević, Josef Škoda, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Diverse Pharmacological Potential of Various Substituted Pyrimidine Derivatives
Abdulaziz Alsharif, Mamdouh Allahyani, Mohammed Al Mohaini, et al.
Current Organic Chemistry (2023) Vol. 27, Iss. 20, pp. 1779-1798
Closed Access | Times Cited: 7
Exceptionally long-lived nuclear RNAs
Jeanne B. Lawrence, Lisa L. Hall
Science (2024) Vol. 384, Iss. 6691, pp. 31-32
Open Access | Times Cited: 2
Harnessing nucleotide metabolism and immunity in cancer: a tumour microenvironment perspective
Hani Suleiman, Alexandra J Emerson, Peter M. Wilson, et al.
FEBS Journal (2024)
Open Access | Times Cited: 2
Characterization of uridine-cytidine kinase like-1 nucleoside kinase activity and its role in tumor growth
Emily C. Matchett, Elise C. Ambrose, Jacki Kornbluth
Biochemical Journal (2022) Vol. 479, Iss. 11, pp. 1149-1164
Open Access | Times Cited: 10
Selective vulnerability of human-induced pluripotent stem cells to dihydroorotate dehydrogenase inhibition during mesenchymal stem/stromal cell purification
Ziadoon Al-Akashi, Denise Zujur, Daisuke KAMIYA, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
DHODH: a promising target in the treatment of T-cell acute lymphoblastic leukemia
Amy Sexauer, Gabriela Alexe, Karin Gustafsson, et al.
Blood Advances (2023) Vol. 7, Iss. 21, pp. 6685-6701
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top